|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.446
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.407
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.366
|
Rat |
|
|
blood circulation
|
GO:0008015 |
195 |
0.326
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.298
|
Human Zebrafish |
|
|
muscle contraction
|
GO:0006936 |
101 |
0.277
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.231
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.227
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.226
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.203
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.187
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.184
|
Rat |
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.184
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.182
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.179
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.172
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.168
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.167
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.164
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.158
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.158
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.158
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.157
|
Mouse |
|
|
regulation of cardiac cell fate specification
|
GO:2000043 |
1 |
0.157
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.157
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.152
|
Rat |
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.152
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.147
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.146
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.143
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.142
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.140
|
Human Zebrafish |
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.138
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.137
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.132
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.131
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.129
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.123
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.122
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.121
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.116
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.113
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.111
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.111
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.111
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.109
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.107
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.105
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.105
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.105
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.103
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.103
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.102
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.101
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.099
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.099
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.099
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.098
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.098
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.097
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.095
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.095
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.092
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.092
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.092
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.091
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.091
|
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
26 |
0.090
|
|
|
|
endothelial cell differentiation
|
GO:0045446 |
41 |
0.089
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.088
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.088
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.087
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.086
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.085
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.084
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.081
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.080
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.080
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.078
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.078
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.078
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.078
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.078
|
Rat |
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.077
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.076
|
|
|
|
elastic fiber assembly
|
GO:0048251 |
4 |
0.075
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.075
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.074
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.074
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.073
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.072
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.072
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.070
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.070
|
|
|
|
heart trabecula formation
|
GO:0060347 |
14 |
0.068
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.068
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.068
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.067
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.067
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.066
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.066
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.066
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.066
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.066
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.064
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.064
|
|
|
|
satellite cell activation involved in skeletal muscle regeneration
|
GO:0014901 |
3 |
0.063
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.063
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.062
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.061
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.061
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.060
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.060
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.060
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.059
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.059
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.059
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.059
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.058
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.057
|
|
|
|
endothelium development
|
GO:0003158 |
45 |
0.057
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.057
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.057
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.057
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.056
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.056
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.055
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.055
|
|
|
|
trunk neural crest cell migration
|
GO:0036484 |
4 |
0.055
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.055
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.055
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.054
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.053
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.053
|
|
|
|
compartment pattern specification
|
GO:0007386 |
4 |
0.053
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.052
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.052
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.051
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.051
|
Human |
|
|
cartilage development
|
GO:0051216 |
140 |
0.051
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.051
|
|
|
|
positive regulation of bone remodeling
|
GO:0046852 |
13 |
0.051
|
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.050
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.050
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.050
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.050
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.049
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.049
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.049
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.048
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.048
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.048
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.048
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.048
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.048
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.047
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.047
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.047
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.047
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.046
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.046
|
|
|
|
adherens junction organization
|
GO:0034332 |
28 |
0.046
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.045
|
|
|
|
endothelial cell apoptotic process
|
GO:0072577 |
9 |
0.045
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.045
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.044
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.044
|
|
|
|
ventricular cardiac muscle cell action potential
|
GO:0086005 |
4 |
0.044
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.044
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.043
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.043
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.043
|
|
|
|
substrate adhesion dependent cell spreading
|
GO:0034446 |
30 |
0.043
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.043
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.042
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.042
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.042
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.042
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.042
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.041
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.041
|
|
|
|
cell migration involved in kidney development
|
GO:0035787 |
3 |
0.041
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.041
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.041
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.041
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.041
|
|
|
|
endocardial cell differentiation
|
GO:0060956 |
4 |
0.041
|
|
|
|
positive regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway
|
GO:0035793 |
1 |
0.040
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.040
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.040
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.040
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.040
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.039
|
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.039
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.039
|
|
|
|
positive regulation of catecholamine secretion
|
GO:0033605 |
2 |
0.039
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.039
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.039
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.039
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.039
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.039
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.038
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.038
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.038
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.038
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.038
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.038
|
|
|
|
morphogenesis of an endothelium
|
GO:0003159 |
2 |
0.038
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.038
|
|
|
|
regulation of bone remodeling
|
GO:0046850 |
28 |
0.038
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.038
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.037
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.037
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.037
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.037
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.036
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.036
|
|
|
|
acetylcholine secretion neurotransmission
|
GO:0014055 |
2 |
0.036
|
|
|
|
regulation of actin filament length
|
GO:0030832 |
45 |
0.036
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.036
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.036
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.036
|
|
|
|
regulation of satellite cell activation involved in skeletal muscle regeneration
|
GO:0014717 |
3 |
0.036
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.036
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.035
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.035
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.035
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.035
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.035
|
|
|
|
chondrocyte development
|
GO:0002063 |
24 |
0.035
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.035
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.035
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.034
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.034
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.034
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.034
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.034
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.034
|
|
|
|
positive regulation of metanephric mesenchymal cell migration
|
GO:2000591 |
1 |
0.034
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.034
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.034
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.033
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.033
|
|
|
|
superoxide metabolic process
|
GO:0006801 |
27 |
0.033
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.033
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.033
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.033
|
|
|
|
acetylcholine transport
|
GO:0015870 |
2 |
0.033
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.032
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.032
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.032
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.032
|
|
|
|
response to epidermal growth factor
|
GO:0070849 |
4 |
0.032
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.031
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.031
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.031
|
|
|
|
cell adhesion mediated by integrin
|
GO:0033627 |
18 |
0.031
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.031
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.031
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.031
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in smooth muscle cell differentiation
|
GO:2000721 |
2 |
0.031
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.031
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.031
|
|
|
|
regulation of acetylcholine secretion neurotransmission
|
GO:0014056 |
2 |
0.031
|
|
|
|
positive regulation of lens epithelial cell proliferation
|
GO:2001111 |
1 |
0.030
|
|
|
|
regulation of hippo signaling
|
GO:0035330 |
1 |
0.030
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.030
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.030
|
|
|
|
cardiac cell fate specification
|
GO:0060912 |
2 |
0.030
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.030
|
|
|
|
regulation of cardiac muscle contraction
|
GO:0055117 |
21 |
0.030
|
|
|
|
cardiac endothelial cell differentiation
|
GO:0003348 |
4 |
0.030
|
|
|
|
regulation of bone resorption
|
GO:0045124 |
24 |
0.030
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.030
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.029
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.029
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.029
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.029
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.029
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.029
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.029
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.029
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.029
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.028
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.028
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.028
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.028
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.028
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.028
|
|
|
|
milk ejection
|
GO:0060156 |
1 |
0.028
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.028
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.028
|
|
|
|
regulation of extracellular matrix assembly
|
GO:1901201 |
2 |
0.028
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.028
|
|
|
|
metanephric glomerular basement membrane development
|
GO:0072274 |
1 |
0.028
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.027
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.027
|
|
|
|
regulation of cell shape
|
GO:0008360 |
39 |
0.027
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.027
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.027
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.026
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.026
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.026
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.026
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.026
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.026
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.026
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.026
|
|
|
|
cgmp metabolic process
|
GO:0046068 |
20 |
0.026
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.026
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.025
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.025
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.025
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.025
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.025
|
|
|
|
positive regulation of satellite cell activation involved in skeletal muscle regeneration
|
GO:0014718 |
2 |
0.025
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.025
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.025
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.025
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.025
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.025
|
|
|
|
endothelial cell development
|
GO:0001885 |
20 |
0.025
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.025
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.025
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.025
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.025
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.024
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.024
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.024
|
|
|
|
muscle cell fate specification
|
GO:0042694 |
1 |
0.024
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.024
|
|
|
|
integrin mediated signaling pathway
|
GO:0007229 |
27 |
0.024
|
|
|
|
cardiac conduction system development
|
GO:0003161 |
12 |
0.024
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.024
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.024
|
|
|
|
regulation of endothelial cell apoptotic process
|
GO:2000351 |
9 |
0.024
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.024
|
|
|
|
termination of rna polymerase i transcription
|
GO:0006363 |
2 |
0.024
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.024
|
|
|
|
acetate ester transport
|
GO:1901374 |
2 |
0.024
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.024
|
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
60 |
0.024
|
|
|
|
dendritic spine maintenance
|
GO:0097062 |
4 |
0.024
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.024
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.023
|
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.023
|
|
|
|
notochord development
|
GO:0030903 |
20 |
0.023
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
35 |
0.023
|
|
|
|
ascending aorta morphogenesis
|
GO:0035910 |
3 |
0.023
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.023
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.023
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.023
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.023
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.023
|
|
|
|
granulocyte migration
|
GO:0097530 |
43 |
0.023
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.023
|
|
|
|
regulation of actin polymerization or depolymerization
|
GO:0008064 |
45 |
0.023
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.023
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.022
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.022
|
|
|
|
prostate gland morphogenetic growth
|
GO:0060737 |
4 |
0.022
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.022
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.022
|
|
|
|
microglia development
|
GO:0014005 |
2 |
0.022
|
|
|
|
metanephric mesangial cell differentiation
|
GO:0072209 |
1 |
0.022
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.022
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.022
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.022
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.022
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.022
|
|
|
|
trabecula formation
|
GO:0060343 |
24 |
0.022
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.022
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.022
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.022
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.022
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.022
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.022
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.022
|
|
|
|
cell communication by chemical coupling
|
GO:0010643 |
2 |
0.022
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.021
|
|
|
|
lamellipodium organization
|
GO:0097581 |
29 |
0.021
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.021
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.021
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.021
|
|
|
|
regulation of lamellipodium assembly
|
GO:0010591 |
3 |
0.021
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.021
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.021
|
|
|
|
mesangial cell differentiation
|
GO:0072007 |
4 |
0.021
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.021
|
|
|
|
basement membrane assembly
|
GO:0070831 |
2 |
0.021
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.021
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.021
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.021
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.020
|
|
|
|
regulation of endothelial cell differentiation
|
GO:0045601 |
10 |
0.020
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.020
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.020
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.020
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
52 |
0.020
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.020
|
|
|
|
ascending aorta development
|
GO:0035905 |
3 |
0.020
|
|
|
|
regulation of vasculogenesis
|
GO:2001212 |
9 |
0.020
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.020
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.020
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.020
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.020
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.020
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.020
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.020
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.020
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.020
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.020
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.020
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.019
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.019
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.019
|
|
|
|
negative regulation of phagocytosis
|
GO:0050765 |
4 |
0.019
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.019
|
|
|
|
negative regulation of glial cell proliferation
|
GO:0060253 |
4 |
0.019
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.019
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.019
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.019
|
|
|
|
endodermal digestive tract morphogenesis
|
GO:0061031 |
4 |
0.019
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.019
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.019
|
|
|
|
extracellular matrix assembly
|
GO:0085029 |
12 |
0.019
|
|
|
|
blood vessel lumenization
|
GO:0072554 |
2 |
0.019
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.018
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.018
|
|
|
|
ventricular trabecula myocardium morphogenesis
|
GO:0003222 |
11 |
0.018
|
|
|
|
positive regulation of bone resorption
|
GO:0045780 |
13 |
0.018
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.018
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.018
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.018
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.018
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.018
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.018
|
|
|
|
regulation of cell projection assembly
|
GO:0060491 |
38 |
0.018
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.018
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.018
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.018
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.018
|
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.018
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.018
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.018
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.018
|
|
|
|
vegf activated neuropilin signaling pathway
|
GO:0038190 |
2 |
0.018
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.018
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.018
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.018
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.018
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.017
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.017
|
|
|
|
positive regulation of thymocyte migration
|
GO:2000412 |
2 |
0.017
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.017
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.017
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.017
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.017
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.017
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.017
|
|
|
|
negative regulation of cartilage development
|
GO:0061037 |
17 |
0.017
|
|
|
|
negative regulation of blood vessel endothelial cell migration
|
GO:0043537 |
3 |
0.017
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.017
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.017
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.017
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.017
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.017
|
|
|
|
negative regulation of b cell receptor signaling pathway
|
GO:0050859 |
4 |
0.017
|
|
|
|
retina vasculature morphogenesis in camera type eye
|
GO:0061299 |
10 |
0.017
|
|
|
|
regulation of endothelial cell migration
|
GO:0010594 |
22 |
0.017
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.017
|
|
|
|
cartilage development involved in endochondral bone morphogenesis
|
GO:0060351 |
24 |
0.017
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.017
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.017
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.017
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.017
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.016
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.016
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.016
|
|
|
|
positive regulation of phospholipase activity
|
GO:0010518 |
3 |
0.016
|
|
|
|
regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway
|
GO:1900238 |
1 |
0.016
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.016
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.016
|
|
|
|
neurotransmitter secretion
|
GO:0007269 |
62 |
0.016
|
|